INTRODUCTION {#SEC1}
============

Regulatory, small RNAs (sRNAs) are found in nearly all bacterial species and implicated in important processes such as virulence, biofilm formation, host interactions and antibiotic resistance ([@B1]). These sRNAs typically regulate messenger RNA (mRNA) translation through imperfect base pairing near an mRNA's ribosomal binding site ([@B2],[@B4]). In many bacterial species, the stability and function of sRNAs are supported by global RNA-binding proteins, such as the protein Hfq ([@B1],[@B4],[@B7]). Given that Hfq is not present in all bacterial species and that not all sRNAs depend on Hfq for their function, there is increasing interest in other RNA-binding proteins that may play a role in global gene-regulation in bacteria ([@B2],[@B10]), including a class of proteins that contain FinO domains ([@B14]).

The *Escherichia coli* protein FinO is the founding member of the FinO structural class of RNA-binding proteins. In *E. coli*, FinO binds the FinP sRNA and regulates the 5′ untranslated region (UTR) of *traJ* ([@B18],[@B19]). Similarly, *Legionella pneumophila* RocC contains a FinO-domain and binds the sRNA RocR along with at least four 5′ UTRs of mRNAs involved in competence ([@B20]). In *E. coli*, another FinO-domain-containing protein called ProQ was initially characterized as an RNA-binding protein contributing to osmoregulation through expression of *proP* ([@B21]). Recently, Grad-Seq experiments have demonstrated that ProQ binds dozens of cellular RNAs ([@B17]), including a large number of sRNAs and mRNA 3′UTRs in *Salmonella* and *E. coli* ([@B22]). ProQ binding has been shown to regulate mRNA-expression levels through interactions with both 5′ and 3′ UTRs. It has been shown to form a ternary complex with an sRNA (RaiZ) and an mRNA (*hupA*), to support RaiZ's repression of *hupA* ([@B23]), and to protect mRNAs from exonucleolytic degradation by binding to 3′ ends ([@B22]). Further, ProQ supports the sRNA SraL in preventing premature termination of *rho* transcripts in *Salmonella* ([@B24]), and promotes *Salmonella* invasion of HeLa cells ([@B25]). ProQ has higher binding affinity for duplex RNA than ssRNA *in vitro* and global analysis of ProQ-bound RNAs using UV CLIP-seq suggests that ProQ interacts with highly structured RNAs, with a simple 12-bp hairpin as the consensus motif ([@B21],[@B22]). This is consistent with *in vitro* analysis showing that FinO's binding affinity for FinP RNA depends on the presence of an RNA duplex rather than the sequence of bases within the duplex, and that FinO protects the base of RNA duplex stems and the nucleotides immediately 3′ of the stem ([@B26],[@B27]). However, the specific determinants of ProQ's binding preferences for cellular RNAs have yet to be determined.

ProQ's domain architecture consists of structured N-terminal and C-terminal domains (NTD, CTD) with a poorly conserved and likely unstructured linker connecting them ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). NMR structures for both conserved domains of *E. coli* (*Ec*) ProQ have been solved, demonstrating that the NTD adopts a FinO-like fold ([@B28]). RNA-binding studies have offered conflicting information about the domain(s) responsible for RNA binding: the NTD/FinO-domain of ProQ has been shown to be sufficient for high-affinity binding to dsRNA *in vitro* ([@B21]), as has the FinO-domain of RocC for high affinity binding to the RocR sRNA ([@B20]). On the other hand, biophysical data indicate that the chemical environment of residues both in the NTD and also in the linker and CTD change in the presence of RNA substrates ([@B28]). Within the NTD/FinO-domain of ProQ, a crosslinking study found that lysine and arginine residues on both surfaces of structure contacted RNA ([@B29]), while biophysical experiments implicate one face more than the other in RNA binding ([@B28]). Thus, there is still significant uncertainty about the functional RNA-binding domains and surfaces of ProQ. Critically, there has been no comprehensive mutagenesis conducted to map the functional binding surface of ProQ in recognizing its sRNA and mRNA substrates.

We have previously reported a transcription-based bacterial three-hybrid (B3H) assay that facilitates the detection of RNA-protein interactions inside of living *E. coli* reporter cells ([@B30]). While this assay was effective in detecting numerous Hfq--sRNA interactions, it was unclear how generally applicable this assay would be to other RNA--protein interactions. Here, we present a modified B3H assay that is able to robustly and specifically detect ProQ--RNA interactions, and providing us with a molecular genetic tool to further investigate the mechanisms of ProQ's interactions with its RNA substrates. We utilize this assay as a platform for targeted mutation of highly conserved residues as well as an unbiased forward genetic screen to define the functional RNA-binding surface(s) of ProQ. We have identified multiple single-point mutations that disrupt ProQ's interaction with target RNAs. Our data suggest that the conserved N-terminal FinO-domain is the principal site of RNA binding *in vivo* for both an sRNA and a 3′UTR. Using available NMR structures for the ProQ NTD, and guided by the results of our forward and reverse genetic approaches, we present a working model for molecular recognition between ProQ and interacting RNAs. We demonstrate the necessity of more than eight residues across a highly conserved face of the NTD for strong RNA binding by ProQ. The chemical nature and location of these residues suggest that ProQ uses a combination of electrostatic, hydrogen-bonding and hydrophobic interactions over a large surface area to mediate RNA interactions. We propose that ProQ achieves specificity for duplex RNAs by acting as an electrostatic scaffold, with the overall structure of the NTD/FinO-domain serving to position several charged residues in an appropriate geometry to recognize the shape of an RNA double helix.

MATERIALS AND METHODS {#SEC2}
=====================

Bacterial strains and plasmids {#SEC2-1}
------------------------------

A complete list of plasmids, strains, and oligonucleotides (oligos) used in this study is provided in [Supplemental Tables S1--S3](#sup1){ref-type="supplementary-material"}, respectively. NEB 5-alpha F'Iq cells (New England Biolabs) were used as the recipient strain for all plasmid constructions.

A single-copy O~L~2-62-*lacZ* reporter on an F' episome bearing tetracycline resistance was generated as previously described ([@B31],[@B32]) by conjugative delivery of pFW11-derivative plasmid pFW11-O~L~2-tet into FW102 cells to generate *E. coli* strain KB480, which is analogous to O~L~2-62-*lacZ* reporters carried on F' episomes bearing kanamycin resistance ([@B30],[@B33]). The *Δhfq::kan* allele and *ΔproQ::kan* allele from the Keio collection ([@B34]) were introduced to KB480 via P1 transduction to generate KB483 and SP2 respectively. An analogous process was used to create strain KB511 from by conjugative delivery of pFW11-derivative plasmid pKB1067 into FW102 cells. pKB1067 was generated from pFW11~tet~ O~L~2-62-*lacZ* from overlap PCR with oKB1366 + oKB1367 to insert a 21 bp-sequence (GCTGCCACGGTGCCCGACCGT) immediately downstream of O~L~2 site. Thus, KB511 carries a single copy *O~L~2-83-lacZ* reporter on F' episome bearing tetracycline resistance, in which the lambda operator *O~L~2* is centered at a position of −83 relative to the transcription start site (TSS). The recombinant F' episome was then moved via conjugation into *Δhfq* strain KB496 to give strain SP5, which was used as the reporter strain for the unbiased screen (described below). Except for this screen and data presented in Figure [1](#F1){ref-type="fig"}, KB483 (*O~L~2-62-lacZ; Δhfq*) was used as the reporter strain for all B3H experiments in this study.

![Adaptation of an *E. coli* bacterial three-hybrid (B3H) interaction to detect ProQ-RNA interactions. (**A**) Design of B3H system to detect interaction between ProQ and an RNA (*cspE* 3′UTR). Interaction between protein moiety ProQ and RNA moiety *cspE* fused, respectively, to the NTD of the alpha subunit of RNAP (α) and to one copy of the MS2 RNA hairpin (MS2^hp^) activates transcription from test promoter, which directs transcription of a *lacZ* reporter gene. The test promoter (p*lac*-O~L~2-62), which bears the λ operator O~L~2 centered at position --62 relative to the transcription start site, is present on a single copy F' episome. The RNA-binding moiety MS2^CP^ is fused to λCI (CI-MS2^CP^) to tether the hybrid RNA (MS2^hp^-*cspE*) to the test promoter. Compatible plasmids direct the synthesis of the α-fusion protein (under the control of an IPTG-inducible promoter), the CI-MS2^CP^ adapter protein (under the control of a constitutive promoter; pCW17) and the hybrid RNA (under the control of an arabinose-inducible promoter). (**B--E**) Results of β-galactosidase assays performed with wild type (B; *hfq^+^proQ^+^*), Δ*proQ* (C) or Δ*hfq* (D,E) reporter strain cells containing three compatible plasmids: one (α±ProQ^ΔCTD^ that encoded α alone (−) or the α-ProQ^ΔCTD^ (+) fusion protein (resi = 2--176, WT or an R80A mutant), another (CI±MS2^CP^) that encoded λCI alone (−) or the λCI-MS2^CP^ fusion protein (+), and a third (MS2^hp^±*cspE*) that encoded a hybrid RNA with the 3′ UTR of *cspE* (pSP10, final 85 nts) following one copy of an MS2^hp^ moiety (+) or an RNA that contained only the MS2^hp^ moiety (−). Cells were grown in the presence of 0.2% arabinose and 50 μM IPTG (see Methods). All subsequent assays were performed in Δ*hfq* reporter strain cells. Bar graphs show the averages of three independent measurements and standard deviations. (**F**) Samples from (D) and (E) were analyzed by Western blot and probed with an anti-ProQ antibody detect α-ProQ^ΔCTD^ fusion protein (α-ProQ). A cross-reacting band independent of the presence of endogenous ProQ or α-ProQ fusion protein is used as a loading control (load; see [Supplementary Figure S3](#sup1){ref-type="supplementary-material"}). Duplicate biological samples are shown.](gkaa144fig1){#F1}

Plasmids were constructed as specified in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}. PCR mutagenesis to create site-directed mutants of *proQ* was conducted with the Q5 Site-Directed Mutagenesis Kit (New England Biolabs) using end-to-end primers designed with NEBaseChanger. The construction of key parent vectors is described below. Residues 2--119, 2--131, 2--176, 181--232 and 2--232 of *Ec* ProQ were fused to the α-NTD (residues 1--248) in pBRα between NotI and BamHI to generate pSP90 (pBRα-ProQ^NTD^), pKB951 (pBRα-ProQ^NTD+12aa^), pKB955 (pBRα-ProQ^ΔCTD^), pSP92 (pBRα-ProQ^CTD^) and pKB949 (pBRα-ProQ^FL^, full-length) respectively.

pCW17 (pAC-p~constit~-λCI-MS2^CP^) was derived from pKB989 (pAC-p~lacUV5~-λCI-MS2^CP^) ([@B30]) by substitution of the region between −35 and +22 of the p~lacUV5~ promoter (containing the −35, −10 and *lacO* elements) with the following sequence lacking a *lacO* element (predicted −35, −10 and TSS of the resulting constitutive promoter are underlined): CTCGAG[ACGATA]{.ul}GCTAGCTCAGTCCTAGG[TATAGT]{.ul}GCTAGC[G]{.ul}CATGC. Stepwise, this substitution was made using Gibson Assembly of a backbone (PCR product of oCW6 and oCW7 on pKB989) and insert (hybridization of oCW18 and oCW19), followed by mutagenesis PCR on the resulting plasmid (with primers oCW28 and oCW29).

pCH1 (pCDF-pBAD-1xMS2^hp^-XmaI-HindIII) was derived from pKB845 (pCDF-pBAD-2x MS2^hp^-XmaI-HindIII) ([@B30]), by removing 2xMS2^hp^ moieties via vector digestion (EcoRI + XmaI) followed by ligation of an insert formed by kinase-treated oCH1 + oCH2, which encodes an EcoRI site, one copy of a 21-nt RNA hairpin from bacteriophage MS2 (MS2^hp^), and an XmaI site. All hybrid RNAs used in this study are 1xMS2^hp^-RNA hybrids and constructed by inserting the RNA of interest into the XmaI/HindIII sites of pCH1. The full sequence of each hybrid RNA is provided in [Supplementary Table S4](#sup1){ref-type="supplementary-material"}.

β-Galactosidase assays {#SEC2-2}
----------------------

For B3H assays, reporter cells (KB480, KB483 or SP2) were freshly co-transformed with compatible pAC-, pBR- and pCDF-derived plasmids, as indicated. From each transformation three colonies (unless otherwise noted) were picked into 1 ml LB broth supplemented with carbenicillin (100 μg/ml), chloramphenicol (25 μg/ml), tetracycline (10 μg/ml), spectinomycin (100 μg/ml) and 0.2% arabinose in a 2 ml 96-well deep well block (VWR), sealed with breathable film (VWR) and shaken at 900 rpm at 37°C. Overnight cultures were diluted 1:50 into 200 μl LB supplemented as above, with an additional 50 μM isopropyl-β-[d]{.smallcaps}-thiogalactoside (IPTG) when noted. Cells were grown to mid-log (OD~600~ ≈ 0.6) in optically clear 200 μl flat bottom 96-well plates (Olympus) covered with plastic lids, as above. Cells were lysed and β-galactosidase (β-gal) activity was measured as previously described ([@B35]). B3H interactions are calculated and reported as the fold-stimulation over basal levels; this is the β-gal activity in reporter cells containing all hybrid constructs (α-ProQ, CI-MS2^CP^ and MS2^hp^-Bait-RNA), divided by the highest activity from negative controls---cells containing plasmids where one of the hybrid constructs is replaced by an α empty, CI empty or MS2^hp^ empty construct. Assays were conducted in biological triplicate on at least three separate days. Absolute β-gal values from a representative dataset of a biological triplicate experiment, including values for all negative controls, are shown in [Supplementary Figures S4 and S6](#sup1){ref-type="supplementary-material"} as mean β-gal values arising from one triplicate experiment. Unless otherwise indicated, B3H interactions are reported in main-text figures as average values of fold-stimulation over basal levels from at least three experiments across multiple days and the standard deviation of these average values from multiple independent experiments.

Western blots {#SEC2-3}
-------------

Cell lysates from β-gal assays were normalized based on pre-lysis OD~600~. Lysates were mixed with 6× Laemmli loading dye with PopCulture Reagent (EMD Millipore Corp), boiled for 10 min at 95°C and electrophoresed on 10--20% Tris--glycine gels (Thermo Fisher) in 1× NuPAGE MES Running Buffer (Thermo Fisher). Proteins were transferred to PVDF membranes (BioRad) using a semi-dry transfer system (BioRad Trans-blot Semi-Dry and Turbo Transfer System) according to manufacturer\'s instructions, and probed with 1:10 000 primary antibody (anti-RpoA-NTD; Neoclone or anti-ProQ; kindly provided by G. Storz) overnight at 4°C and then a horseradish peroxidase (HRP)-conjugated secondary antibody (anti-mouse IgG or anti-rabbit IgG; Cell Signaling, 1:10 000). Note that, throughout the paper, 'anti-ProQ' is written out rather than using the standard abbreviation of 'α-ProQ.' This is to avoid confusion with the fusion protein we call 'α-ProQ' consisting of the NTD of RpoA (α) fused in frame to ProQ. Chemiluminescent signal from bound peroxidase complexes was detected using ECL Plus western blot detection reagents (BioRad) and a c600 imaging system (Azure) according to manufacturer\'s instructions.

Random mutagenesis {#SEC2-4}
------------------

A mutant *proQ* library was generated first by 30 rounds of PCR amplification of the *proQ* portion of the pBRα-ProQ^FL^ plasmid (pKB949) using Phusion DNA Polymerase (New England Biolabs) in 70 mM MgCl~2~, 500 mM KCl, 100 mM Tris (pH 8.0), 0.1% bovine serum albumin, 2 mM dGTP, 2 mM dATP, 10 mM dCTP, 10 mM dTTP and primers oKB1077 and oKB1078. A second mutant *proQ* library was generated under the same condition but with the addition of 0.1 mM MnCl~2~. The PCR products of both libraries were digested with DpnI (New England Biolabs) to remove template plasmid, then with NotI-HF and BamHI-HF (New England Biolabs), gel purified, and ligated (T4 DNA ligase; New England Biolabs) into a pBRα vector cut with NotI-HF and BamHI-HF. Following ligation and transformation into NEB 5-alpha F'Iq cells (New England Biolabs), cells were grown as near-lawns on LB-carbenicillin plates and a miniprep was performed from resuspension of ∼23 000 colonies to yield the plasmid library.

B3H screening and dot blots {#SEC2-5}
---------------------------

For dot-blots, cell lysates (3 ul) from β-gal assays were transferred to nitrocellulose Protran membranes (Amersham) by multichannel pipette. Membranes were allowed to dry, then probed and imaged as above. To verify that the dot-blot assay could identify destabilized α-ProQ proteins, 10 *proQ* mutants were sequenced, all of which resulted in reduced β-gal activity on plates and in liquid, five of which showed reduced levels by dot blot and five of which showed approximate wild-type-levels by dot blot. There was a 100% correspondence between the levels of ProQ indicated by dot blot and the presence or absence of a premature stop codon in the NTD ([Supplementary Table S4](#sup1){ref-type="supplementary-material"}).

For the primary screen, the pBRα-proQ plasmid library was transformed into SP5 cells along with pCW17 (pACλCI-MS2^CP^) and pSP10 (pCDF-MS2^hp^-*cspE*) or pSP14 (pCDF-MS2^hp^-SibB) and plated on LB agar supplemented with inducers (0.2% arabinose and 1.5 μM IPTG), antibiotics (carbenicillin (100 μg/ml), chloramphenicol (25 μg/ml), tetracycline (10 μg/ml) and spectinomycin (100 μg/ml)) and indicators (5-bromo-4-chloro-3-indolyl-β-[d]{.smallcaps}-galactopyranoside (Xgal; 40 μg/ml) and phenylethyl-β-[d]{.smallcaps}-thiogalactopyranoside (TPEG; 75 μM; Gold Biotech)). These conditions were chosen to enable a clear distinction between blue positive-control colonies (containing the WT fusion proteins and the *cspE* hybrid RNA) and white negative-control colonies (instead containing a plasmid encoding α-empty). Reporter strain SP5, (*O~L~2-83-lacZ;*) was used only for the high-throughput screen and results of RNA-binding defects were subsequently verified in KB483 (*O~L~2-62-lacZ*). Plates were incubated overnight at 37°C, then at 4°C for an additional ∼48 h. 536 white or pale colonies were isolated (372 against *cspE* + 164 against SibB), and liquid β-gal assays were conducted to confirm the effects of these white colonies, followed by a dot-blot counter-screen with anti-ProQ antibody to eliminate mutants with low expression levels. To analyze dot-blot results of colonies that were identified in the primary screen, densitometry was conducted using ImageJ software to quantify the intensity of individual dots. The intensity of each dot was normalized to the OD~600~ of the culture before lysis and β-gal activity of each colony was plotted against normalized ProQ intensity. Normalized intensities were compared to positive and negative controls and colonies with ProQ-expression levels in the wild-type range were selected for sequencing.

Plasmids were isolated from 86 colonies that produced low β-gal activity but wild-type levels of α-ProQ fusion protein, and the DNA encoding *proQ* in each pBRα-*proQ* plasmid was sequenced. 37 colonies were found to carry pBRα-*proQ* plasmids containing single mutations that encoded unique substitutions in α-ProQ. Mini-prepped plasmids from these colonies were re-transformed into KB483 reporter cells already carrying pCW17 (pACλCI-MS2^CP^) and pSP10 (pCDF-1xMS2^hp^-*cspE*) or pSP14 (pCDF-1xMS2^hp^-SibB). Liquid β-gal assays were conducted as above, with induction of α-ProQ from both 0 and 50 μM IPTG, and ProQ-expression levels were evaluated in triplicate at IPTG concentrations. The basal level β-gal activity was set by activity in reporter cells containing an α-empty plasmid rather than an pBRα-*proQ* plasmid isolated in the screen. Average fold-stimulation of β-gal activity and dot-blot intensities of each mutant were then normalized to the values of WT α-ProQ (set to 1.0) and α-empty (set to 0.0) using the expression (Value~mutant~ -- Value~α-empty~)/(Value~WT,0\ IPTG~ -- Value~α-empty,0\ IPTG~). Note that relative expression and fold-stimulation of each mutant at 0 μM and 50 μM IPTG can be directly compared to one another, as both sets of values were normalized to WT α-ProQ at 0 μM IPTG.

RESULTS {#SEC3}
=======

Establishing a B3H assay for ProQ--RNA interactions {#SEC3-1}
---------------------------------------------------

Our previous studies with the bacterial three-hybrid (B3H) assay have focused on Hfq--RNA interactions ([@B30]). We sought to determine whether this B3H assay could detect interactions of ProQ with RNA in an analogous manner to the interactions of RNA and Hfq. The *cspE* 3′UTR was chosen as an initial RNA candidate due to its strong interaction with ProQ that has been observed both *in vivo* and *in vitro* ([@B22],[@B28]). To simplify the possibility of multiple ProQ domains interacting with RNA, we began our analysis with a construct possessing only the ProQ NTD and linker (residues 2--176; hereafter ProQ^ΔCTD^). For the envisioned assay, ProQ^ΔCTD^, the 'prey' protein, is fused to the N-terminal domain of the alpha subunit of RNAP (α; Figure [1A](#F1){ref-type="fig"}). A single-copy test promoter contains the operator O~L~2 centered 62-bp upstream from the transcription-start site (TSS) of a *lacZ* reporter gene. The 3′-terminal 85 nts of the *cspE* transcript (hereafter *cspE*) serves as the 'bait' and is expressed as a hybrid RNA following either one or two copies of a 21-nt RNA hairpin from bacteriophage MS2 (MS2^hp^). This hybrid RNA is tethered to the upstream O~L~2 DNA sequence via a constitutively expressed RNA--DNA 'adapter' protein consisting of a fusion between the CI protein from bacteriophage λ (CI) and the coat protein from bacteriophage MS2 (MS2^CP^). In this system, interaction between DNA-tethered *cspE* RNA and the RNAP-assembled α-NTD-ProQ fusion protein stabilizes the binding of RNAP to the test promoter, thereby activating reporter gene expression.

Our previous studies with Hfq utilized hybrid RNA constructs with two copies of the 21-nt MS2^hp^ RNA as has been used extensively in yeast three-hybrid systems ([@B30],[@B36]). Given that a single MS2^hp^ can interact with an MS2^CP^ dimer and that FinO-domain proteins are known to interact with stem--loops ([@B22],[@B26],[@B27],[@B37]), we first investigated whether the presence of two MS2^hp^ moieties alone would stimulate *lacZ* expression in the B3H system with α-ProQ^ΔCTD^, even before another 'bait' RNA was added ([Supplementary Figure S2A](#sup1){ref-type="supplementary-material"}). β-Galactosidase (β-gal) assays show that *lacZ* expression is stimulated when a 2XMS2^hp^ RNA is present with both α-ProQ^ΔCTD^ and CI-MS2^CP^ ([Supplementary Figure S2B](#sup1){ref-type="supplementary-material"}, top); this was not observed when α-Hfq was used as a prey protein ([Supplementary Figure S2B](#sup1){ref-type="supplementary-material"}, bottom). Importantly, *lacZ* expression is not stimulated when only a single MS2^hp^ is present ([Supplementary Figure S2B](#sup1){ref-type="supplementary-material"}; rows 4 versus 5), suggesting that, while ProQ can interact with an MS2^hp^ if given the opportunity, a single hairpin is unable to interact with both CI-MS2^CP^ and α-ProQ in a manner that stimulates *lacZ* transcription in the B3H assay. In order to avoid non-specific transcriptional stimulation by an interaction between the second MS2^hp^ moiety and ProQ, we chose to move forward with hybrid RNAs expressing bait RNAs following a single copy of the MS2^hp^.

Using a 1XMS2^hp^-*cspE* hybrid RNA, we asked whether the interaction of *cspE* with α-ProQ^ΔCTD^ would stimulate *lacZ* expression from the −62-O~L~2 test promoter (Figure [1A](#F1){ref-type="fig"}). β-Gal assays show that transcription from the test promoter is stimulated slightly (∼1.4-fold) when all three hybrid components are present, as compared to the basal activity from the negative controls where any single element (ProQ, *cspE* or MS2^CP^) is left out from 'empty' constructs that express only α, MS2^hp^ or CI, respectively (Figure [1B](#F1){ref-type="fig"}). We next wondered whether the ProQ-*cspE* B3H interaction might be limited by competition with endogenous ProQ or cellular Hfq, given that co-immunoprecipitation studies have suggested that ProQ and Hfq may compete for a subset of their RNA substrates ([@B22],[@B38]). While no additional stimulation of transcription over basal levels was observed when the ProQ-*cspE* B3H experiment was repeated in Δ*proQ* reporter cells (Figure [1C](#F1){ref-type="fig"}; 1.2×), we found that the fold-stimulation of β-gal transcription indeed increased in Δ*hfq* reporter cells (Figure [1D](#F1){ref-type="fig"}; 2.3×). To confirm that the stimulation of β-gal transcription in these cells was dependent on functional ProQ, we sought to disrupt the ProQ--*cspE* B3H interaction with a point substitution. We chose Arg80 as a conserved residue, which has previously been proposed to mediate RNA interactions ([@B28]), to replace with alanine within the ProQ fusion protein. Unlike with WT ProQ, no stimulation of β-gal transcription was observed in the B3H experiment when the α-ProQ^ΔCTD^ fusion protein contained an R80A substitution (Figure [1E](#F1){ref-type="fig"} versus D). The R80A variant is expressed at comparable levels to WT (Figure [1F](#F1){ref-type="fig"}), indicating that this loss of interaction is not due to destabilization of the fusion protein by the alanine substitution. We therefore concluded that use of a Δ*hfq* reporter strain allowed for the most robust detection of ProQ-RNA interactions in our B3H assay. This Δ*hfq* reporter strain was previously used for detecting Hfq--RNA interactions ([@B30]), and is used throughout the remainder of this study. The fold-stimulations in these experiments, while modest, are comparable to those observed for Hfq-OxyS interactions, which were previously sufficient to conduct informative forward and reverse genetic analyses of Hfq RNA-binding surfaces ([@B30]).

Scope of detectable RNA interactions {#SEC3-2}
------------------------------------

Given that ProQ has been found to interact with dozens of sRNAs and hundreds of mRNAs inside of *Salmonella* and *E. coli* cells ([@B17],[@B22]), we sought to determine whether our B3H system could detect ProQ interactions with additional RNAs beyond *cspE*. We tested three additional RNAs that had been found to interact *in vivo* with ProQ: sRNAs SibB, RyjB and the 3′UTR of *fbaA* (hereafter, *fbaA*) ([@B17],[@B22],[@B38]); as well as four sRNAs for which we had previously detected B3H interactions with Hfq: ChiX, OxyS, ArcZ and MgrR ([Supplementary Figure S4](#sup1){ref-type="supplementary-material"}) ([@B30]). While a *cspE* hybrid RNA consistently produced the highest stimulation of transcription above basal levels when present with α-ProQ^ΔCTD^ β-gal activity when each of these hybrid RNAs was present in reporter cells (Figure [2A](#F2){ref-type="fig"}; full β-gal data in [Supplementary Figure S5A](#sup1){ref-type="supplementary-material"}). As with *cspE*, β-gal activity arising from each of these hybrid RNAs was disrupted by an R80A point substitution (Figure [2B](#F2){ref-type="fig"}). In addition, a hybrid RNA containing an arbitrary RNA sequence (the *trpA* terminator, T~trpA~) did not interact with the ProQ fusion protein, though it is possible the lack of interaction is due to the shorter length of this T~trpA~ RNA. To compare the RNA-binding activity of ProQ to Hfq in this assay, we tested the same panel of nine hybrid RNAs for interaction with α-Hfq ([@B30]). While interactions were detected for the four established Hfq-dependent sRNAs, α-Hfq did not stimulate β-gal transcription with any of the hybrid RNAs chosen as putative ProQ interactors (Figure [2C](#F2){ref-type="fig"}). We conclude that, against this panel of eight RNAs, and in the absence of endogenous Hfq, ProQ binds to a range of RNAs that co-immunoprecipitate with either ProQ or Hfq ([@B17],[@B39]). As hybrid RNAs containing *cspE* and SibB yielded the highest B3H signal with ProQ, we focused further analysis on these two RNAs -- one 3′UTR (*cspE*) and one sRNA (SibB).

![B3H assay detects ProQ's interaction with multiple RNA substrates. Results of B3H assays between a panel of RNA substrates with (**A**) wild-type ProQ (**B**) an R80A variant or (**C**) wild-type *E. coli* Hfq. β-galactosidase assays were performed with *Δhfq* reporter strain cells containing three compatible plasmids: one that encoded λCI or the CI-MS2^CP^ fusion protein, another that encoded α or an α-fusion protein (α-ProQ^ΔCTD^, either with wild type ProQ or an R80A mutant or α-Hfq), and a third that encoded a hybrid RNA (a single MS2^hp^ moiety fused to *cspE* 3′ UTR, SibB, *fbaA* 3′ UTR, RyjB, ArcZ, ChiX, MgrR, OxyS, trpA terminator (T~trpA~) or an RNA that contained only the MS2^hp^ moiety. The cells were grown in the presence of 0.2% arabinose and 50 μM IPTG (see Materials and Methods). Absolute β-gal values of a representative dataset are shown in [Supplementary Figure S5A](#sup1){ref-type="supplementary-material"}.](gkaa144fig2){#F2}

ProQ NTD is sufficient for binding *cspE* and SibB RNAs *in vivo* {#SEC3-3}
-----------------------------------------------------------------

Conflicting evidence has been collected about the contributions of the linker and CTD of ProQ to RNA binding ([@B20],[@B21],[@B28],[@B40]). In order to assess the contribution of these ProQ domains to RNA binding *in vivo*, we compared the binding of five domain-truncation mutants of ProQ (Figure [3A](#F3){ref-type="fig"}; full β-gal data in [Supplementary Figure S5B](#sup1){ref-type="supplementary-material"}) with *cspE* and SibB RNAs. All fusion proteins were expressed inside of the cell at least as well as full-length (FL) protein, as assessed by an antibody recognizing the region of α shared by each protein (Figure [3B](#F3){ref-type="fig"}). Removal of the CTD did not significantly alter the observed interactions with either *cspE* or SibB (FL versus ΔCTD) and the CTD on its own did not afford any detectable interaction with either hybrid RNA (Figure [3C](#F3){ref-type="fig"}, D), despite the fact that the CTD alone construct is expressed at higher levels than FL protein (Figures [3B and S5C](#F3){ref-type="fig"}). Removal of the unstructured linker did not weaken ProQ's interaction with *cspE* but did result in reduced interaction with SibB (ΔCTD versus NTD). Interestingly, a construct with only the first 12aa of the 61-aa linker partially restored the interaction of ProQ with SibB (NTD+12aa versus NTD; see Discussion). Together, our results indicate that the ProQ CTD is not required for interaction with either the *cspE* 3′UTR or SibB RNAs *in vivo* and that the NTD/FinO-domain is the primary RNA-binding site for both of these RNAs.

![NTD is the primary site of interaction with *cspE* and SibB RNAs *in vivo*. (**A**) Schematic of α-ProQ domain-truncation mutants used in B3H assays, (**B**) Western blot with anti-RpoA antibody showing expression of α-ProQ truncations in lysates from samples in (**C**) and (**D**). The position of full-length endogenous RpoA (α; 37 kDa) and two molecular weight markers are indicated. Results of B3H assays detecting interactions between α-ProQ truncations and (C) *cspE* and (D) SibB RNAs. β-galactosidase assays were performed with *Δhfq* reporter strain cells containing three compatible plasmids: one that encoded λCI alone or the CI-MS2^CP^ fusion protein, another that encoded α or an α-fusion protein (α-ProQ^FL^ (full-length; residues = 2--232), α-ProQ^ΔCTD^ (residues = 2--176), α-ProQ^NTD+12aa^ (residues = 2--131), α-ProQ^NTD^ (residues = 2--119), or α-ProQ^CTD^ (residues = 181--232)), and a third that encoded a hybrid RNA (MS2^hp^-*cspE* or MS2^hp^-SibB) or an RNA that contained only the MS2^hp^ moiety. The cells were grown in the presence of 0.2% arabinose and 50 μM IPTG (see Methods). Absolute β-gal values of a representative dataset are shown in [Supplementary Figure S5B](#sup1){ref-type="supplementary-material"}. Quantification of the Western blot is shown in [Supplementary Figure S5C](#sup1){ref-type="supplementary-material"}.](gkaa144fig3){#F3}

Conserved NTD residues mediate RNA interactions {#SEC3-4}
-----------------------------------------------

Having established that the NTD/FinO-domain of ProQ is sufficient for interaction with both *cspE* and SibB RNAs *in vivo*, we wanted to identify amino acids in the NTD beyond Arg80 that are required for RNA interaction. Hereafter, we call the two faces of the ProQ NTD the 'concave face' (containing H2 and H3 as primary structural features) and 'convex face' (containing H1 and β1/2 as structural feature; [Supplementary Figure S1A](#sup1){ref-type="supplementary-material"}, Figure [4A](#F4){ref-type="fig"}) to be consistent with nomenclature used for other FinO-domain proteins ([@B14]). Mapping degree-of-conservation onto the ProQ NMR structure, we noticed a large patch of highly conserved residues on the concave face ([Supplementary Figure S1B](#sup1){ref-type="supplementary-material"}), and wondered whether these residues are important for RNA binding. To explore this possibility, we identified residues that are both highly conserved across 15 ProQ/FinO-domain proteins ([Supplementary Figure S6](#sup1){ref-type="supplementary-material"}) and surface exposed in the NMR structure to target for mutagenesis in the α-ProQ^ΔCTD^ construct (Figure [4A](#F4){ref-type="fig"}--[C](#F4){ref-type="fig"}).

![Effects of specific disruptive amino acid substitutions on B3H interactions. Positions of (**A**) basic, (**B**) hydrophobic and (**C**) acidic residues targeted for site-directed mutagenesis shown on ProQ NTD Structure (PDB ID: 5nb9) ([@B28]). Residue coloring, used throughout: highly conserved basic, blue; less conserved basic, cyan; hydrophobic, orange; aromatic, yellow; acidic, red). (D--F, left) Inset in (B) shows surface representation with the hydroxyl group of Tyr70 colored red. Inset in (C) shows β-3,4 hairpin in stick representation, with atoms colored by element. Dashed lines indicate potential hydrogen bonds, involving the polypeptide backbone (yellow), Asp82 (red) or Asp41 (purple). Results of B3H assays showing effects on ProQ--RNA interactions of alanine mutations at (D) basic, (E) hydrophobic and (F) acidic residues. β-galactosidase assays were performed with *Δhfq* reporter strain cells containing three compatible plasmids: one that encoded λCI or the CI-MS2^CP^ fusion protein, another that encoded α or an α-ProQ^ΔCTD^ fusion protein (wild type, WT, or the indicated mutant), and a third that encoded a hybrid RNA (MS2^hp^-*cspE* or MS2^hp^-SibB) or an RNA that contained only the MS2^hp^ moiety. (**D**, **E**) Cells were grown in the presence of 0.2% arabinose and 50 μM IPTG. (**F**) Cells were grown in the presence of 0.2% arabinose. The bar graph shows the fold-stimulation over basal levels as averages and standard deviations of values collected from two independent experiments conducted in triplicate across multiple days. Absolute β-gal values of a representative dataset are shown in [Supplementary Figure S7](#sup1){ref-type="supplementary-material"}. (D--F, right) Western blot to compare steady-state expression levels of mutant α-ProQ^ΔCTD^ fusion proteins. Lysates were taken from the corresponding β-gal experiment containing MS2^hp^-*cspE* and all other hybrid components at 50 μM. Following electrophoresis and transfer, membranes were probed with anti-ProQ antibody (see [Supplementary Figure S3](#sup1){ref-type="supplementary-material"}). Loading controls and quantification of blots are shown in [Supplementary Figure S8](#sup1){ref-type="supplementary-material"}.](gkaa144fig4){#F4}

Given the negative electrostatic nature of RNA, we focused first on contributions of positively charged residues on the NTD surface. The recent NMR structure of *Ec* ProQ revealed that both faces of the NTD/FinO-domain possess patches of positively charged residues ([Supplementary Figure S1C](#sup1){ref-type="supplementary-material"}) ([@B28]), leading to ambiguity about which would be most important for RNA binding. We selected six basic residues to substitute individually with alanine---four highly conserved (Lys35, Lys54, Arg58, Arg80; Figure [4A](#F4){ref-type="fig"}, blue) and two more modestly conserved (Lys75, Lys107; Figure [4A](#F4){ref-type="fig"}, cyan). Altered forms of the ProQ fusion protein were expressed at levels comparable to WT (Figure [4D](#F4){ref-type="fig"}, right; [Supplementary Figure S8A and D](#sup1){ref-type="supplementary-material"}) and removal of highly conserved basic residues (R58A, R80A and K54A variants) strongly reduced interaction with *cspE* and SibB hybrid RNAs, while the K35A variant demonstrated preferential loss of interaction with SibB (Figure [4D](#F4){ref-type="fig"}; full β-gal data in [Supplementary Figure S7](#sup1){ref-type="supplementary-material"}). Substitution of the less conserved basic residues with alanine (K75A and K107A variants) had more modest effects on RNA interaction (Figure [4D](#F4){ref-type="fig"}). Together, these results suggest that the concave face of the NTD/FinO-domain contributes to RNA binding along with Arg80 which has been modeled on the convex face of ProQ (see Discussion), and that conservation of surface-exposed residues correlates with their role in RNA binding.

Two of the most highly conserved residues along the NTD's concave face are aromatic and hydrophobic residues in which the side chains are partially surface exposed: Tyr70 and Leu71 (Figure [4B](#F4){ref-type="fig"}). As such residues can mediate intermolecular interactions, we wished to determine whether they contribute to RNA binding. Substitution of Leu70 with alanine significantly reduced the interaction of ProQ^ΔCTD^ with both *cspE* and SibB hybrid RNAs without strong effects on expression levels of the ProQ fusion protein (Figure [4E](#F4){ref-type="fig"}; [Supplementary Figure S8B and E](#sup1){ref-type="supplementary-material"}). Even very conservative substitutions at this position (Ile or Val) resulted in decreased RNA interaction, especially in the case of SibB (Figure [4E](#F4){ref-type="fig"}), consistent with hydrophobic interactions depending on the size and shape of aliphatic chains. When the neighboring Tyr70 residue was altered, both Y70S and Y70F ProQ variants showed a loss of RNA interaction despite WT-levels of expression (Figure [4E](#F4){ref-type="fig"}). That Phe and Ser are each insufficient for RNA interaction at this position indicates that both the hydroxyl group and aromatic ring of Tyr70 are critical for RNA interaction with *cspE* and SibB (see Discussion).

We next examined the role of two highly conserved acidic residues, Asp41 and Asp82, positioned close to one another in the folded protein (Figure [4C](#F4){ref-type="fig"}). Alanine substitution at each position strongly impaired interaction of ProQ with the RNAs (Figure [4F](#F4){ref-type="fig"}). We next tested subtler structural changes at these positions by replacing Asp with Glu, extending the side chain by a single --CH~2~-- group. While α-ProQ^ΔCTD^ with a D41E substitution was able to interact well with both *cspE* and SibB hybrid RNAs, a D82E substitution strongly impaired interaction with both RNAs (Figure [4F](#F4){ref-type="fig"}), while all four ProQ variants were comparably stable to WT (Figure [4F](#F4){ref-type="fig"}, right; [Supplementary Figure S8C and F](#sup1){ref-type="supplementary-material"}). This suggests that the precise positioning of the Asp82 carboxylate moiety is needed to support RNA binding. This could arise from the carboxylate either forming hydrogen bond(s) to RNA and/or within the ProQ structure or coordinating a cation, perhaps aided by the nearby Asp41. To distinguish between these possibilities, we tested whether the negative charge of Asp82 is necessary for RNA binding, or if hydrogen-binding ability of this sidechain is sufficient to support RNA binding by ProQ. A neutral Asn residue at this position (D82N) was able to partially rescue binding of α-ProQ^ΔCTD^ to *cspE* and SibB (Figure [4F](#F4){ref-type="fig"}). These results suggest that the precise positioning of the Asp82 side chain, but not its negative charge, is critical for RNA interaction by ProQ; its role in RNA binding may be mediated at least in part through structural stabilization of the β-hairpin in which it resides (Figure [4C](#F4){ref-type="fig"}; see Discussion). Together, our site-directed-mutagenesis results demonstrate the importance of numerous residues across the conserved concave-face of the ProQ NTD, along with Arg80 on the opposite surface, in contributing -- directly or indirectly -- to interactions with *cspE* and SibB RNAs.

Unbiased genetic screen confirms role of concave face in RNA interactions {#SEC3-5}
-------------------------------------------------------------------------

Our site-directed-mutagenesis results strongly implicated the concave face of the NTD/FinO-domain as a critical site for RNA binding in the context of ProQ^ΔCTD^, but it is possible this analysis overlooked other critical regions of the protein. We therefore used our genetic B3H assay to conduct an unbiased forward genetic screen to identify ProQ residues critical for RNA binding. We began with a library of mutagenized plasmids containing full-length *proQ* (α*-proQ^FL^*) to leave open the possibility of finding substitutions anywhere in the protein that would disrupt interaction with either *cspE* or SibB hybrid RNAs. We first confirmed that the ProQ-B3H interactions we had observed in liquid were also apparent when cells were grown on X-gal-containing indicator medium and found a robust difference in colony color between positive and negative controls ([Supplementary Figure S9A](#sup1){ref-type="supplementary-material"}). For the screen, B3H reporter-strain cells containing the CI-MS2^CP^ adapter protein and either the MS2^hp^-*cspE* or MS2^hp^-SibB hybrid RNA were transformed with a PCR-mutagenized α-*proQ^FL^* plasmid library estimated to contain ∼23 000 unique mutants, and plated on X-gal indicator medium (see Methods). In this primary screen, ∼15% of colonies were white or pale, the phenotype expected for transformants that contained α-*proQ* mutants that no longer interacted with a hybrid RNA ([Supplementary Figure S9B](#sup1){ref-type="supplementary-material"}). To eliminate the subset of colonies containing plasmids encoding mutations resulting in unstable fusion proteins, we established a dot-blot assay in which lysates from single colonies could be spotted on nitrocellulose membranes and probed with an anti-ProQ antibody. Indeed, the dot-blot assay displayed strong signal above an α-empty negative control, even in a *proQ^+^* reporter strain, and a suitable linear range for the intended counter-assay ([Supplementary Figure S9C](#sup1){ref-type="supplementary-material"}; see Materials and Methods). From the 536 white or pale colonies identified in the primary screen (372 isolated against *cspE* + 164 against SibB RNA), the dot-blot assay identified the subset (∼30%) that maintained wild-type levels of expression ([Supplementary Figure S9D](#sup1){ref-type="supplementary-material"}).

We sequenced α-*proQ* plasmids from colonies displaying strong defects in RNA binding while retaining high levels of fusion-protein expression ([Supplementary Figure S9E](#sup1){ref-type="supplementary-material"}, purple oval). Sequencing reads unambiguously covering the entirety of the *proQ* sequence were obtained for 86 mutant plasmids, of which 54 were found to harbor a single mutation; nearly a third of mutant plasmids were independently isolated multiple times (Table [1](#tbl1){ref-type="table"}). Together, these plasmids encoded 37 distinct amino-acid substitutions at 25 residues in ProQ that disrupt interaction with one or both RNAs used in our screen (Table [1](#tbl1){ref-type="table"}). We confirmed the loss of RNA interaction of these 37 α-ProQ^FL^ variants in liquid β-gal assays with both *cspE* and SibB hybrid RNAs, and verified their stability via dot-blot assays ([Supplementary Table S6](#sup1){ref-type="supplementary-material"}). These experiments were conducted at two IPTG concentrations to examine RNA-binding across a range of α-ProQ^FL^ expression levels. Results from these experiments demonstrate that none of the RNA-binding defects of the 37 α-ProQ^FL^ variants identified here are attributable to reduced protein expression relative to WT.

###### 

Results of forward genetic screen for ProQ substitutions that disrupt RNA binding. Each row represents a plasmid isolated from the screen one or more times which expressed a variant α-ProQ^FL^ protein that was expressed at wild-type or greater levels and nevertheless displayed reduced b-galactosidase activity with either *cspE* or SibB hybrid RNAs. Columns indicate (i) the residues in α-ProQ^FL^ at which substitutions were found to disrupt RNA binding in B3H screen, (ii) the position of each residue based on the ProQ NTD NMR structure (PDB: 5nb9) ([@B28]), either within the core of the protein, on the surface or buried, but on the periphery outside of the core (see [Supplementary Figure S10](#sup1){ref-type="supplementary-material"}), (iii) the specific amino-acid substitution resulting from mutation in each isolated plasmid and (iv) the number of times this mutated plasmid was isolated in screening against either a MS2^hp^-*cspE* or MS2^hp^-SibB RNAs

                                                Times isolated   
  ----------------- ----------------- --------- ---------------- ---
  L17               Core              L17P      1                1
  R20               Surface           R20P                       1
  F21               Buried            F21S                       1
  C24               Core              C24W      1                
                                      C24R                       1
  F25               Core              F25C      1                
                                      F25S      2                1
                                      F25Y                       1
  L34               Core              L34R      1                
                                      L34Q                       1
                                      L34P                       1
  K35               Surface           K35E                       1
                                      K35N                       1
                                      K35I                       1
  G37               Surface           G37V                       1
  I38               Core              I38S      1                
  L42               Core              L42S                       1
  L57               Core              L57S      1                
  A60               Core              A60D      1                
  L63               Surface           L63P                       1
  Y64               Core              Y64C      1                
                                      Y64N      1                1
  S66               Surface           S66P      1                1
  Y70               Surface           Y70H      2                1
  L71               Surface           L71P      2                1
  R80               Surface           R80C      1                
                                      R80H      1                
                                      R80S                       2
  V81               Core              V81D      2                1
  D82               Surface           D82Y                       1
  L83               Core              L83F      1                
                                      L83P                       1
  G85               Surface           G85D      1                1
  L91               Buried            L91Q                       1
                                      L91R      1                
  Q102              Surface           Q102P                      1
  L103              Buried            L103P                      1
  **25 residues**   **37 variants**   **24×**   **26×**          

Notably, despite beginning this screen with a library of mutations in full-length *proQ*, all 25 residues implicated by the screen in RNA binding are located in the FinO-like NTD. Nearly all ProQ variants, whether identified in the screen against either RNA, resulted in diminished interaction with *both cspE* and SibB hybrid RNAs ([Supplementary Table S5](#sup1){ref-type="supplementary-material"}), suggesting that ProQ binds both of these RNAs with a similar surface and molecular mechanism (see Discussion). Of the implicated residues, the NMR structure suggests that 14 are likely to be buried in the protein structure, while 11 residues are surface-exposed ([Supplementary Figure S10A--C](#sup1){ref-type="supplementary-material"}) ([@B28]). To validate the screen\'s results, we set aside variants at presumed buried residues as likely to perturb the overall structure of the protein, and further set aside surface-exposed residues we had already investigated through site-directed mutagenesis (Lys35, Tyr70, Leu71, Arg80, Asp82). This left six previously unexamined surface-exposed residues suggested by our screen to contribute to RNA binding ([Supplementary Figure S10E](#sup1){ref-type="supplementary-material"}). Many mutations identified by the screen at these positions produced non-conservative substitutions, such as the introduction of a proline residue (Table [1](#tbl1){ref-type="table"}; [Supplementary Figure S10C](#sup1){ref-type="supplementary-material"}). To determine whether loss of RNA interaction for each variant arose from the absence of a wild-type residue or the presence a destabilizing one, we made site-directed alanine substitutions in α-ProQ^ΔCTD^ at each position. When Arg20, Leu63, Ser66 and Gln102 were each replaced with alanine, RNA binding was not strongly impaired ([Supplementary Figure S10E, F](#sup1){ref-type="supplementary-material"}). Substitutions at these positions with proline likely emerged from our screen due to structural disruption by proline rather than the native residues contributing essential molecular contacts with RNA. In contrast, alanine substitutions at two glycine positions (Gly37 and Gly85) strongly disrupted RNA binding without affecting expression of each fusion protein ([Supplementary Figure S10D-F](#sup1){ref-type="supplementary-material"}). Given the nature of glycine\'s side chain, it is likely that the strong effects of these substitutions also act through the conformation of the polypeptide (see Discussion). Finally, we mapped all of the validated residues identified by our forward-genetic screen to be necessary for RNA interaction on to the ProQ NMR structure (Figure [5A](#F5){ref-type="fig"}). This highlights a patch of RNA-binding residues along the concave face and wrapping around to Arg80 which is strikingly similar to the surface identified by site-directed mutagenesis (Figure [4A](#F4){ref-type="fig"}--[C](#F4){ref-type="fig"}). In addition to residues already probed through site directed-mutagenesis, Gly37 is located on the conserved concave face of the NTD (Figure [5A](#F5){ref-type="fig"}), while Gly85 is a part of the β3-4 hairpin that contains Arg80 and Asp82 (Figure [5B](#F5){ref-type="fig"}; see Discussion).

![Validated genetic-screen results and model for ProQ--dsRNA interactions. (**A**) Surface representation of ProQ NTD structure (PDB ID: 5nb9) ([@B28]), viewed from concave (left) or convex (right) surface, showing residues at which substitutions were found to disrupt RNA binding in B3H screens of mutagenized *α-ProQ^FL^* plasmids and at which substitution with alanine has been confirmed to be sufficient to disrupt binding (Figure [4](#F4){ref-type="fig"} and [Supplementary Figure S10E](#sup1){ref-type="supplementary-material"}; residue coloring: basic, blue; hydrophobic, orange; aromatic, yellow; acidic, red; polar: purple; glycine: green). (**B**) Inset shows close-up view of β3/4 hairpin, viewed from the convex face. Under a transparent surface representation, the polypeptide backbone is shown as a cartoon and amino-acid side chains are represented sticks, colored as in (A). Side chains for residues Asp84 and Asn86 (not identified as RNA-binding residues in screen) are shown as gray sticks. (**C**) Summary of results from both site-directed and unbiased mutagenesis experiments. Surface representation of ProQ NTD structure, viewed from concave (left) or convex (right) surface, showing all residues identified in this study as necessary for strong RNA interactions *in vivo* whether from site-directed mutagenesis (Figure [4](#F4){ref-type="fig"}) or a forward genetic screen (A) and colored as in (A). (**D**) Preliminary structural model for ProQ NTD recognition of dsRNA. Transparent surface and cartoon representation of ProQ NTD viewed from concave face, hand-docked in PyMol (version 1.6.2) and COOT (version 0.8.9.2) ([@B52]) to a 12-bp RNA duplex (PDB ID: 5DA6) ([@B51]) using only rigid rotations of the protein and RNA structure (left) or to a 10 bp RNA duplex and adjacent ssRNA from a RydC crystal structure (PDB ID: 4v2s) ([@B50]), using rigid rotations of the dsRNA, and rotations around phosphates of ssRNA (right). dsRNA is shown as a tan cartoon with phosphates as spheres, and adjacent ssRNA is shown as a brown cartoon. Three phosphates that have a suitable geometry to interact with basic residues (Lys35, Lys54 and Arg58) are colored in red. Two structural models that place these phosphates in an appropriate orientation to interact with these concave-face basic residues are shown: one in which an RNA duplex interacts with ProQ in an edge-on manner (left) and one in which it interacts in an end-on manner (right). Both of these models are consistent with our genetic data, though an end-on interaction is more consistent with biochemical data for FinO-domain proteins (see text). ProQ and residues are colored as in (C) with side chains of RNA-binding residues shown as sticks.](gkaa144fig5){#F5}

Potential for dsRNA recognition by ProQ RNA-binding residues {#SEC3-6}
------------------------------------------------------------

While there are multiple ways that the ProQ residues we have identified could contribute to RNA binding, we wished to develop a preliminary structural model that would combine results from our forward and reverse genetic approaches (Figure [5C](#F5){ref-type="fig"}) with literature results suggesting a strong preference for ProQ to bind structured RNAs ([@B22]), and FinO requiring both a stem and neighboring ssRNA for strong binding to FinP RNA ([@B26],[@B27]). We noticed that the group of RNA-binding residues we have identified spans 15--20 Å across the concave face of the NTD, similar to the width of an A-form RNA helix. Thus, we propose a model in which the concave face of the NTD/FinO-domain recognizes the duplex region of an RNA substrate, with Arg80 on the convex face potentially interacting with a more flexible region of nearby RNA. As electrostatics often predominate interaction with RNAs, we examined the positions of three conserved basic concave-face residues (Arg58, Lys54, Lys35) implicated in RNA binding by our genetic analyses. Docking of a duplex RNA structure onto the ProQ NTD structure shows that these three residues are positioned in such a way to facilitate electrostatic interactions with phosphates across the width of an A-form-RNA helix (Figure [5D](#F5){ref-type="fig"}; phosphates proposed to be contacted are shown as red spheres). While interactions that are either 'edge-on' or 'end-on' with respect to the RNA duplex (Figure [5D](#F5){ref-type="fig"}, [Supplementary Figure S11](#sup1){ref-type="supplementary-material"}) are consistent with our mutagenesis results, an interaction of ProQ with the base of a duplex in an 'end-on' manner is more consistent with previous observations that FinO strongly protects the very base of RNA hairpins ([@B27]). Such an 'end-on' interaction would also allow single-stranded RNA on either side of the duplex to adopt paths that pass additional residues identified by our mutagenesis experiments---toward Tyr70 and Leu71 on one side of the duplex and towards the β-3,4 hairpin containing Arg80 and Asp82 on the other ([Supplementary Figure S11B](#sup1){ref-type="supplementary-material"}). Based on this preliminary modeling, we propose that the ProQ NTD/FinO-domain could serve as a scaffold for the patterned display of charged residues, positioned in such a way to recognize the shape of the negatively-charged backbone of duplex RNA.

DISCUSSION {#SEC4}
==========

In this work, we have conducted the first comprehensive mutagenesis study of ProQ to identify the functional surface used by ProQ to bind to RNA substrates. In order to apply both forward and reverse genetic approaches to this question, we adapted a bacterial three-hybrid (B3H) assay for genetic detection of RNA-protein interactions to report on binding of ProQ to RNA. Using this system, we have established that the NTD/FinO-domain of ProQ is the primary site that mediates interaction with *cspE* and SibB RNAs *in vivo* and have dissected the roles of residues on multiple surfaces of this domain in RNA binding. Results from both forward- and reverse-genetic analyses are in strong agreement with one another, converging to implicate the more highly conserved surface of the NTD, which we call the concave face, as the primary site for recognition of both RNAs. We have proposed a working structural model that interprets the positions of residues identified in this study as critical for RNA binding in light of ProQ's established preference for binding to structured RNAs. In this model, the global structure of the NTD/FinO-domain pre-positions highly conserved residues across the concave face to recognize the conserved shape and charge of double-stranded RNA. By allowing conservation to guide our initial studies and taking an unbiased genetic approach, we have demonstrated that, along with basic residues, conserved acidic, aromatic and hydrophobic residues also play an important role in ProQ's ability to bind RNA.

Insights into RNA-binding surfaces of ProQ {#SEC4-1}
------------------------------------------

The relative roles in RNA binding played by disordered regions and structured domains of ProQ/FinO-like proteins have been a subject of inquiry over several years ([@B20],[@B21],[@B28],[@B29]). Two lines of evidence from our study suggest that the ProQ NTD/FinO-domain is the primary *in vivo* binding site for interaction with the two RNAs closely investigated here. First, truncation analysis demonstrates that the ProQ NTD, along with the first 12 aa of the linker, is sufficient for full interaction with both the 3′ UTR of *cspE* and the sRNA SibB. Further, an unbiased forward genetic screen starting with mutagenized full-length *proQ* did not identify any mutations in the region encoding the linker or CTD that were sufficient to disrupt interaction of ProQ with either hybrid RNA. In contrast, 37 amino-acid substitutions at 25 residues within the NTD/FinO-domain were identified by our screen to disrupt interactions with one or both hybrid RNAs.

While our data support a model in which the NTD/FinO-domain of ProQ is the primary binding site for these two RNAs *in vivo*, we cannot rule out the possibility that other regions in the linker or CTD contribute important interactions with certain RNA substrates. In particular, our data suggest that the most N-terminal 12 aa of the unstructured linker may be necessary for full interaction with certain RNA substrates (e.g. SibB), while not for others (e.g. *cspE*; Figure [3](#F3){ref-type="fig"}). Among these 12 aa in *Ec* ProQ are four basic residues, three of which are immediately adjacent to one another ([Supplementary Figure S6](#sup1){ref-type="supplementary-material"}), and the presence of positively charged residues in this region is common across other ProQ proteins. It is possible that certain RNAs may depend on electrostatic stabilization from the NTD-adjacent region of the linker. It will be interesting to explore this possibility in the future with our panel of RNA substrates using both forward- and reverse-genetic approaches.

Within the NTD/FinO-domain, the majority of RNA-binding residues identified in this study map to the concave face, but Arg80 on the convex face of ProQ is essential for interaction with all eight RNAs we have tested (Figure [2](#F2){ref-type="fig"}). The observation that positively charged residues on both surfaces of the NTD/FinO-domain contribute to RNA binding is consistent with crosslinking studies with *E. coli* FinO that found basic residues on both faces crosslink to FinP RNA, and with biophysical studies suggesting RNA binding on the convex face of ProQ ([@B28],[@B29]). It is striking, however, that Arg80 is the only residue on the convex face of the NTD that our unbiased genetic screen implicated in RNA binding. One intriguing possibility is that, while the concave face may mediate interactions with duplex RNA, the convex face may interact with nearby single-stranded region(s) (Figure [5C](#F5){ref-type="fig"}). It will be important to explore the mechanistic role of Arg80 in RNA-binding further in the future (see below).

ProQ structure and conservation with other FinO-domain proteins {#SEC4-2}
---------------------------------------------------------------

Many of our findings align well with previous results obtained with ProQ and other FinO-domain proteins. For instance, the critical role of the NTD/FinO-domain in RNA interactions is consistent with *in vitro* findings that the FinO-domain of *Ec* ProQ, and also of *L. pneumophila* RocC, is sufficient for high affinity binding to its RNA substrates ([@B20],[@B21]). Further, many of the RNA-binding residues we have identified in *Ec* ProQ are conserved in both of these homologs, as well as in the FinO-containing *N. meningitidis (Nm)* NMB1681 ([Supplementary Figure S12](#sup1){ref-type="supplementary-material"}), and the two positions in FinO that crosslink most strongly to FinP RNA in previous work are located on helix H3 ([@B29]), in similar positions to Lys54 and Arg58 on the concave face of *Ec* ProQ. Previously determined crystal structures of NMB1681 and F' FinO reveal that the conserved residues we have identified as important for RNA binding also map to the concave faces of their respective FinO-domain protein ([Supplementary Figure S12B--D](#sup1){ref-type="supplementary-material"}) ([@B40],[@B41]). It is interesting to note that, in crystal structures of NMB1681 and F' FinO, the arginine corresponding to Arg80 resides on the concave face of the FinO-domain, in a similar position to Lys35 in the ProQ NMR structure ([Supplementary Figure S12C, D](#sup1){ref-type="supplementary-material"}). It is not yet clear whether differences in the modeled position of this residue between FinO and NMB1681 crystal structures and the ProQ NMR structure arise from differences in the structural technique utilized or if they represent genuine structural divergence and/or flexibility in this region of the protein.

A universally conserved residue across all of these FinO-domain proteins is the aromatic residue Tyr70 (*Ec* numbering; [Supplementary Figure S12A](#sup1){ref-type="supplementary-material"}), which appears to play a critical role in the structure and/or function of ProQ. In our random-mutagenesis screen, a Y70H substitution was identified independently as disrupting *cspE* and SibB interactions. Interestingly, a Y-to-F mutation at the analogous position was found in an unbiased screen to disrupt RocR activity in *L. pneumophila* ([@B20]), and the same Y70F substitution in *Ec* ProQ impairs binding with both RNAs we have examined, reaffirming the importance of this hydroxyl group. In the ProQ NMR structure, the aromatic ring of Tyr70 is somewhat buried while the hydroxyl group is pointing towards the surface (Figure [4B](#F4){ref-type="fig"}) ([@B28]), and we cannot rule out that the role of Tyr70 in RNA binding may be mediated at least partially through global structure of ProQ. We note this hydroxyl group is relatively close to backbone amides of Leu34 and Lys35 in *Ec* ProQ (2.5--4.7 Å in various NMR states) and could mediate an intramolecular hydrogen bond within the polypeptide, or could be directly involved in contacting RNA.

Another conserved structural feature across *Ec* ProQ, *Nm* NMB1681 and FinO is the β3--4 hairpin implicated by our data as a critical structural element for RNA interaction by ProQ ([Supplementary Figure S12C,D](#sup1){ref-type="supplementary-material"}) ([@B28],[@B40],[@B41]). In each of these β hairpins, an aspartate is found at the position corresponding to ProQ's Asp82, and is positioned in a way that could stabilize its hairpin through intramolecular hydrogen bond(s) ([Supplementary Figure S12E](#sup1){ref-type="supplementary-material"}). This region in FinO does not crosslink to FinP RNA ([@B29]) and had not been previously appreciated as an element contributing to RNA binding. In this study, however, the β3-4 hairpin featured the highest density of hits in our unbiased genetic screen: in addition to Arg80, Asp82, and Gly85, two additional hydrophobic residues in this β3--4 hairpin (Val81 and Leu83) were disrupted by mutants isolated in our screen. The latter residues appear to pack the β3--4 hairpin into the global core of the ProQ NTD (Figure [5B](#F5){ref-type="fig"}) and are part of a large number of 'core' residues identified by our screen at which substitutions disrupt RNA binding without affecting protein expression levels ([Supplementary Figure S10A, B](#sup1){ref-type="supplementary-material"}; [Supplementary Table S5](#sup1){ref-type="supplementary-material"}). While it seems clear that the β3--4 hairpin plays an important role in RNA binding, our data cannot distinguish between mutations that alter the structure/conformation of ProQ and those that directly perturb RNA-binding residues. It will be exciting for the role of this hairpin to be further explored using biochemical and biophysical techniques.

Underscoring the importance of ProQ conformation in RNA binding, two glycine residues (Gly37 and Gly85) were found in our unbiased screen to be necessary for RNA interaction; even an alanine at these positions prevents interaction with *cspE* and SibB RNAs ([Supplementary Figure S10E](#sup1){ref-type="supplementary-material"}). One interpretation of these results is that a particular and perhaps non-canonical polypeptide conformation at these glycine positions is critical to facilitate RNA binding. Both glycine residues are highly conserved in other FinO-domain proteins ([Supplementary Figure S12](#sup1){ref-type="supplementary-material"}) and located near structural elements that contain additional RNA-binding residues: in the β3--4 hairpin discussed above and at the base of H3 between Lys35 and Asp41 ([Supplementary Figure S12](#sup1){ref-type="supplementary-material"}). Considered together with contributions to RNA binding by residues spanning a wide area across the concave face of the NTD, the disruptive effects of subtle substitutions in both the core and on the surface of ProQ suggest that the global structure of the ProQ NTD/FinO-domain mediates RNA recognition through precise positioning of multiple chemical moieties at a specific distance and orientation to one another.

Relationship between ProQ and other bacterial RNA-chaperone proteins {#SEC4-3}
--------------------------------------------------------------------

There has been interest in the overlap of the subset of cellular RNAs bound by ProQ and Hfq ([@B22],[@B38]), another global RNA-binding protein that stabilizes dozens of sRNAs and catalyzes annealing with mRNAs in *E. coli*. In this study, ProQ was found to bind to a wider range of RNAs than Hfq, producing B3H interactions with RNAs found to interact both with ProQ as well as with Hfq *in vivo* (Figure [2](#F2){ref-type="fig"}). Deletion of endogenous *hfq* from the *E. coli* reporter strain resulted in a strengthened B3H interaction of ProQ and RNA, even more so than deletion of endogenous *proQ* (Figure [1](#F1){ref-type="fig"}). While it is tempting to speculate that this reflects competition of ProQ with Hfq for RNA substrates, it is notable that we do not observe B3H interactions of α-Hfq with *cspE*, SibB, *fbaA* and RyjB, suggesting that any interaction between Hfq and these RNAs is likely weak relative to Hfq-dependent sRNAs. An *Δhfq* reporter strain was previously found to be ideal for Hfq--sRNA B3H interactions ([@B30]). While it is possible that this strain benefits both Hfq- and ProQ--RNA interactions by eliminating competition between endogenous Hfq and the RNAP-bound fusion protein, it is also possible that the benefit arises due to a pleiotropic, indirect effect of *Δhfq*. Collectively, our data are consistent with ProQ and Hfq sharing a subset of RNA targets, as has been suggested by previous studies ([@B22],[@B38]).

*Ec* ProQ, FinO and *Nm* NMB1681 have each been shown to catalyze RNA duplexing and strand exchange to various extents ([@B18],[@B19],[@B21],[@B41]). Whereas Hfq has multiple surfaces with distinct RNA-binding specificity that contribute to RNA annealing, *in vitro* studies suggest that high-affinity RNA-binding of both ProQ and FinO proteins is separable from their chaperone activity ([@B18],[@B21]); in the case of FinO, chaperone activity has been mapped to an N-terminal helical extension that is not conserved in ProQ ([@B18]). For ProQ, both the CTD and NTD have been shown to catalyze strand-exchange with FinP/*traJ* substrates, while the NTD provides high-affinity RNA-binding ([@B21]). It has been proposed that FinO-domain proteins may destabilize RNA stem-loops to support RNA annealing and that kissing-loop interactions between two FinO-bound stem loops could nucleate their base pairing ([@B15],[@B42]). Given the critical role our data suggest for the β-3,4 hairpin, it is intriguing to note that β hairpins can play roles in nucleic-acid melting (*e.g*. promoter melting by T7 RNA polymerase) ([@B43]). It will be exciting to continue to explore the relationship between RNA binding and ProQ's mechanisms of RNA matchmaking and other cellular roles ([@B22],[@B38]).

Whereas FinO has a relatively small number of specific RNA targets, ProQ has been shown to bind to a broad set of RNAs *in vivo* ([@B17],[@B22],[@B38]). While it is well established that Hfq has multiple RNA-binding surfaces that possess distinct RNA-binding specificity and contribute to RNA annealing ([@B6],[@B44]), it is not yet clear to what extent ProQ binds various classes of RNAs with similar or distinct mechanisms. ProQ interacts with nearly all of the RNAs we have tested in this study. The broad range of ProQ's RNA interactions in the B3H assay may reflect the fact that each of these hybrid RNAs possesses a 3′ intrinsic terminator, which is thought to be a site of binding for FinO-domain proteins ([@B22],[@B26],[@B27]). Here, we have investigated the domains and surfaces that mediate interaction with one sRNA and one mRNA 3′UTR, and have found that both of these RNAs are recognized primarily by the highly conserved concave face of the ProQ NTD. SibB is a *cis*-encoded antitoxin sRNA and thus may possess more extensive complementarity with its cognate toxin mRNAs than most Hfq-dependent sRNAs ([@B45],[@B46]). The vast majority of mutations we have examined here have strikingly similar effects on the binding of *cspE* and SibB hybrid RNAs, with a few intriguing exceptions. For instance, the interaction of ProQ with SibB in our B3H assay depends more on the ProQ linker, and on residue Lys35, than that with *cspE*. Given the genetic nature of our assay, it is possible that some of the apparent differences in RNA-binding depend on differential competition between ProQ and other endogenous RNAs, as has been established for Hfq ([@B47]). We look forward to searching for additional RNA-specific binding effects of *proQ* mutations in the future, using a larger set of interacting RNAs, and determining to what extent SibB and *cspE* represent apparent RNA 'classes' of sRNAs and 3′UTR, as well as exploring interactions of 5′UTR-fragments and coding regions, which recent datasets show are quite abundant in ProQ-bound pairs of RNAs ([@B38]).

Outlook {#SEC4-4}
-------

Many questions remain about the structure and function of ProQ, including (i) what the detailed role of Arg80 and the convex face are in RNA binding, (ii) to what extent unique modes of interaction exist for distinct RNAs or classes of RNAs, (iii) whether ProQ mediates RNA annealing and which part(s) of ProQ would contribute to this activity, (iv) which part(s) of ProQ may recruit additional cellular factors, such as the ribosome ([@B48]), RNA polymerase, PNPase ([@B49]) or other factors. The genetic assay we have developed could be useful in several of these pursuits: genetic screens conducted with counter-screens against various RNAs have the potential to identify ProQ substitutions with RNA-specific binding effects. The fact that our interaction assay is conducted *in vivo* means that interactions we detect could be influenced by one or more of the above cellular factors. It is intriguing to imagine that a chromosomal screen could be used to identify cellular factors that influence the state of ProQ--RNA interactions. In addition, the ProQ variants identified in this work will serve as helpful tools to probe the contribution of RNA binding by distinct surfaces to cellular pathways of gene expression. Finally, we look forward to comparing our preliminary genetically-guided model for ProQ's interaction with duplex RNA with a high-resolution co-structure of this complex. Indeed, we anticipate that the model presented in this study can guide future strategies to obtain such a high-resolution structure. The structural details of this protein-RNA recognition event provide an important foundation to further elucidate molecular mechanisms of gene regulation by the global RNA-binding protein ProQ.
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